Italian Laser Giant Quanta System Targets US Market with Direct NC Hub

SAMARATE, Italy & RALEIGH, NC – February 27, 2026 – In a significant strategic pivot, Italian medical laser leader Quanta System S.p.A. has announced the establishment of a direct US subsidiary, Quanta System Inc., in North Carolina. The new entity, set to be fully operational on March 1, 2026, marks a decisive move away from the company's historical reliance on third-party distributors in the world's largest healthcare market.

This initiative plants a flag for the 'Made in Italy' technology brand directly in the competitive American surgical and urology sectors. By creating a direct channel to physicians and hospitals, the company aims to accelerate innovation, enhance customer support, and capture a larger share of a rapidly expanding industry.

“Establishing our headquarters in North Carolina is a statement of our organization's maturity,” said Girolamo Lionetti, CEO of parent company Quanta System S.p.A. “We believe that the US market deserves direct dialogue with the manufacturer. Quanta System Inc. is our answer: a presence that guarantees continuity, stability, internal support, and a long-term vision for our American stakeholders.”

A Strategic Shift in a Booming Market

Quanta System's move is a calculated entry into a highly lucrative and growing field. The US surgical laser market, valued at over USD 3.3 billion in 2024, is projected to surge past USD 6.5 billion by 2030, growing at a compound annual rate of nearly 12%. The urology laser segment is similarly robust, expected to climb from approximately USD 288 million to over USD 416 million in the same period. This growth is fueled by an aging population, a rising prevalence of chronic diseases, and a strong clinical preference for minimally invasive procedures that reduce recovery times and improve patient outcomes.

By going direct, Quanta System is positioning itself to compete head-on with established giants in the space, such as Boston Scientific, Lumenis, and Olympus. The company is betting that its direct model will offer a competitive edge. This approach replaces the traditional distributor buffer with a direct line of communication, a strategy the company believes is essential for success.

The new US operation will be led by Walter Ryan, a seasoned executive appointed as President of Quanta System Inc. With over 26 years in the medical device industry, Ryan brings the experience necessary to navigate the complex American market.

"While our surgical business has historically grown through valued distribution partners...we believe an in-house model allows for closer collaboration, faster feedback, and greater agility," Ryan explained. "This approach enables us to respond more quickly to market needs with innovative products and more targeted marketing strategies."

'Made in Italy' Meets the Research Triangle

The choice of North Carolina for its US headquarters is a strategic masterstroke. The state has meticulously cultivated a reputation as a premier hub for life sciences and medical technology, making it a magnet for international firms. North Carolina is home to the largest manufacturing workforce in the southeastern US and boasts over 75,000 professionals in the life sciences sector.

Quanta System Inc. will be situated within a vibrant ecosystem that includes five Tier-1 research universities and the famed Research Triangle Park (RTP), North America's largest research park. This proximity offers unparalleled opportunities for collaboration, talent acquisition, and clinical research. Furthermore, the state's business-friendly environment, featuring a low 2.5% corporate income tax rate and significantly lower operating costs than other MedTech hubs, provides a solid financial foundation for the new venture. This environment attracted over $10.8 billion in life sciences investment in 2024 alone, cementing its status as a top-tier destination for companies like Quanta System.

Redefining Physician Collaboration and Innovation

At the heart of Quanta's strategy is the promise of a closer, more dynamic relationship with the American medical community. The company asserts that a direct presence will shorten the feedback loop between the surgeons using the technology and the engineers designing it. This synergy is expected to accelerate the development of next-generation laser systems tailored to the specific needs of US clinical practice.

Filippo Fagnani, Vice President of Marketing and Scientific Director of the Surgical Division, emphasized the importance of this proximity. “Establishing a direct presence in the U.S. allows us to work side-by-side with surgeons, ensuring our innovation cycle is directly informed by their needs,” he stated. “This proximity is what enables us to deliver breakthroughs like the Quanta Magneto Technology® precisely where they are needed.”

For hospitals and surgical centers, this translates into the promise of faster service, dedicated technical and clinical support directly from the manufacturer, and more agile responses to maintenance and training needs. Ultimately, the company argues, this enhanced collaboration will lead to improved clinical excellence and patient safety.

This ambitious US expansion is backed by the financial strength and strategic vision of Quanta's parent company, the El.En. Group. As a publicly traded leader on the Euronext STAR Milan exchange, El.En. reported consolidated revenues of €565.8 million in 2024. Its robust financial position, including a positive net financial position of over €110 million at the end of 2024, provides the necessary capital to fund this significant long-term investment in the American market. The move is a clear signal that Quanta System is not just entering the US market, but is here to stay and redefine its presence for-profit medical device business.